Scandinavian Real Heart
16,06
SEK
+7,79 %
HEART
First North Stockholm
Medical Equipment & Services
Health Care
2 investorer følger denne virksomhed
+7,79%
-16,14%
-27,33%
-52,82%
-57,2%
-52,06%
-91,93%
-96,74%
-89,63%
realheart.se
Scandinavian Real Heart operates in medical technology. Today, the company's main focus is on research and development of heart pumps used among patients with severe heart conditions who are in the queue for transplant. The idea behind the heart pump is to use the product as a transitional solution before a final heart transplant is performed. The company is based in Västerås.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
HEART
Daglig lav / høj pris
14,54 / 16,92
SEK
Markedsværdi
33,21 mio. SEK
Aktieomsætning
74,94 t SEK
Volumen
4,6 t
Finanskalender
Årsrapport
26.02.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| European Innovation Council Accelerator | 18,9 % | 18,9 % |
| Eskilstunahem Förvaltnings AB | 8,1 % | 8,1 % |
| Avanza Pension | 4,8 % | 4,8 % |
| Azad Najar | 3,5 % | 3,5 % |
| Jonas Rudberg | 1,3 % | 1,3 % |
| Raux, Gilbert | 1,2 % | 1,2 % |
| Big Bear Holding AB | 0,9 % | 0,9 % |
| Abbe Dikmen | 0,8 % | 0,8 % |
| Nordnet Pensionsförsäkring | 0,8 % | 0,8 % |
| Bilend Najar | 0,6 % | 0,6 % |
ViserAlle indholdstyper
Realheart Is Granted Patent Approval in India for Its Device Used in the Surgical Implantation of Realheart® TAH
Interim Report Q3 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools